OUT, DAMN ZITS

Acne treatments have come a long way since the days when teens slathered their faces with gooey, smellypimple creams.

Adair Greene Healthcare Communications will get its chance to show how far in its upcoming campaigns for Stiefel Laboratories’ Brevoxyl and Clindets brands.

The Atlanta shop’s ads will appear in medical journals targeting physicians and dermatologists.

Brevoxyl has dominated the market for a decade; Clindets, like Brevoxyl, is used to treat mild to moderate acne, but utilizes individually wrapped pads to deliver its antibiotic treatment.

Adair Greene was assigned the business, in part, because of its success with other Stiefel brands.

“We’re proud to have earned Stiefel’s confidence,” said agency general manager Mark Perlotto, who hoped the assignments would build “a growing relationship.”

If the shop delivers on its campaign promises, the relationship with the Coral Gables, Fla.-based pharmaceutical firm could continue for a long time: 80 percent of the U.S. population under 40 still suffers zit eruptions.